Remdesivir therapy causing bradycardia in COVID-19 patients: Two case reports

Remdesivir therapy causing bradycardia in COVID-19 patients: Two case reports

The coronavirus disease 2019 (COVID-19) pandemic has been an enormous public health challenge. The pursuit for an effective therapy led to the use of the antiviral drug Remdesivir for hospitalized patients with severe COVID-19 pneumonia. We reported two cases of patients with severe COVID-19 pneumon...

Full description

Bibliographic Details
Main Authors: Alaaeldin Abdelmajid, Wala Osman, Huda Musa, Hisham Elhiday, Waqar Munir, Muna A. Al.Maslamani, Eman Zeyad Elmekaty
Format: Article
Language:English
Published: Elsevier 2021-01-01
Series:IDCases
Subjects:
Remdesivir
COVID-19
Bradycardia
Viral pneumonia
SARS-CoV-2
Online Access:http://www.sciencedirect.com/science/article/pii/S2214250921002109

Internet

http://www.sciencedirect.com/science/article/pii/S2214250921002109

Similar Items